Epsilon Energy Ltd. Schedules Second Quarter 2025 Earnings Release and Conference Call
Globenewswire· 2025-07-29 04:05
HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that it will issue its second quarter 2025 earnings release on Wednesday, August 13, 2025 after the market close and host a conference call to discuss its financial and operating results on Thursday, August 14, 2025 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time). Interested parties in the United States and Canada may participate toll-free by dialing (833) 816-1385. International p ...
Ekso Bionics Reports Second Quarter 2025 Financial Results
Globenewswire· 2025-07-29 04:05
SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and six months ended June 30, 2025. Recent Highlights and Accomplishments Named Bionic Prosthetics & Orthotics Group (“Bionic P&O”) as its first Ekso Indego Personal device distributor within the orthotics and prosthetics industryAccepted into the NVIDIA C ...
Hanmi Financial to Participate in the 26th Annual KBW Community Bank Investor Conference
Globenewswire· 2025-07-29 04:05
LOS ANGELES, July 28, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced its participation in the 26th Annual KBW Community Bank Investor Conference on Tuesday, July 29 and Wednesday, July 30, 2025, in New York City. Bonnie Lee, President and Chief Executive Officer, and Ron Santarosa, Chief Financial Officer, will host one-on-one and small group meetings during the conference. A copy of the presentation being used ...
Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025
Globenewswire· 2025-07-29 04:05
公司财务报告安排 - 公司将于2025年8月11日上午8点(美国东部时间)举行电话会议和网络直播,报告截至2025年6月30日第一季度财务结果并提供业务更新 [1] - 可通过注册链接电话接入会议,演示文稿和网络直播详情将在公司网站投资者板块“活动与演示”中提供,会议结束后可在网站查看存档网络直播 [2] 公司简介 - 公司是一家生物制药公司,旨在加速重要药物开发和商业化,改善患者生活 [3] - 公司管线包括针对FcRn的全人单克隆抗体IMVT - 1402和batoclimab、TYK2和JAK1强效小分子抑制剂brepocitinib、吸入式sGC激活剂mosliciguat等 [3] - 公司通过创建子公司开发和商业化药物及技术,还孵化与生物制药业务互补的发现阶段公司和健康科技初创企业 [3] 公司联系方式 - 投资者联系Keyur Parekh,邮箱keyur.parekh@roivant.com [7] - 媒体联系Stephanie Lee,邮箱stephanie.lee@roivant.com [8]
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025
Globenewswire· 2025-07-29 04:05
NASHVILLE, Tenn., July 28, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will host a virtual key opinion leader (KOL) event on Friday, August 15, 2025 at 4:00 PM ET featuring Anthony Langone, MD (Associate Professor of Medicine, Division of Nephrology and Hypertension, Vanderbilt University). To register, click here. Dr. Langone, who serves as the national principal investigator (NPI) for iMDx’s ongoing kidney transplant monitoring trial, will discu ...
HF Foods to Report Second Quarter 2025 Results on August 11, 2025
Globenewswire· 2025-07-29 04:05
Company to Host Conference Call with Prepared Remarks and Q&A at 1:30 p.m. PTLAS VEGAS, July 28, 2025 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods”, or the “Company”), a leading distributor of international foodservice solutions to Asian restaurants and other businesses across the United States, today announced it will report financial results for the second quarter ended June 30, 2025, on Monday, August 11, 2025, after market close. The Company will host a conference call to discuss it ...
TFI International Announces 2025 Second Quarter Results
Globenewswire· 2025-07-29 04:05
Second quarter operating income of $170.2 million compares to $206.0 million in the same prior year quarterSecond quarter net income of $98.2 million compares to $115.7 million in Q2 2024, while adjusted net income1 of $112.0 million compares to $145.6 million in Q2 2024Second quarter diluted earnings per share (diluted “EPS”) of $1.17 compares to $1.36 in Q2 2024, while adjusted diluted EPS1 of $1.34 compares to $1.71 in Q2 2024Second quarter net cash from operating activities of $246.7 million compares to ...
Beyond Meat® to Report Second Quarter 2025 Financial Results on August 6, 2025
Globenewswire· 2025-07-29 04:05
EL SEGUNDO, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the second quarter ended June 28, 2025 on Wednesday, August 6, 2025 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. Eastern, 2:00 p.m. Pacific. Investors interested in participating in the live call can dial 785-424-1789. There will be a simultaneous, live w ...
VirTra Sets Second Quarter 2025 Conference Call for Monday, August 11, 2025 at 4:30 p.m. ET
Globenewswire· 2025-07-29 04:05
CHANDLER, Ariz., July 28, 2025 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators and firearms training simulators for the law enforcement and military markets, will hold a conference call on Monday, August 11, 2025 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the second quarter ended June 30, 2025. Financial results will be issued in a press release prior to the call. VirTra ...
Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
Globenewswire· 2025-07-29 04:05
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that data from its DREAM pivotal study was published online in the Journal of Clinical Sleep Medicine. The DREAM pivotal study presents comprehensive 12- ...